Logo image of WEED.CA

CANOPY GROWTH CORP (WEED.CA) Stock Fundamental Analysis

TSX:WEED - Toronto Stock Exchange - CA1380357048 - Common Stock - Currency: CAD

1.69  +0.15 (+9.74%)

Fundamental Rating

2

Taking everything into account, WEED scores 2 out of 10 in our fundamental rating. WEED was compared to 33 industry peers in the Pharmaceuticals industry. WEED scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. WEED is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year WEED has reported negative net income.
WEED had a negative operating cash flow in the past year.
In the past 5 years WEED always reported negative net income.
WEED had a negative operating cash flow in each of the past 5 years.
WEED.CA Yearly Net Income VS EBIT VS OCF VS FCFWEED.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1B -2B -3B

1.2 Ratios

With a Return On Assets value of -65.18%, WEED is not doing good in the industry: 84.85% of the companies in the same industry are doing better.
With a Return On Equity value of -122.76%, WEED is not doing good in the industry: 75.76% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -65.18%
ROE -122.76%
ROIC N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
WEED.CA Yearly ROA, ROE, ROICWEED.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

WEED has a Gross Margin of 30.30%. This is comparable to the rest of the industry: WEED outperforms 51.52% of its industry peers.
The Profit Margin and Operating Margin are not available for WEED so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEED.CA Yearly Profit, Operating, Gross MarginsWEED.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800

4

2. Health

2.1 Basic Checks

WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WEED has more shares outstanding
WEED has less shares outstanding than it did 5 years ago.
WEED has a better debt/assets ratio than last year.
WEED.CA Yearly Shares OutstandingWEED.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
WEED.CA Yearly Total Debt VS Total AssetsWEED.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

WEED has an Altman-Z score of -12.75. This is a bad value and indicates that WEED is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -12.75, WEED is doing worse than 84.85% of the companies in the same industry.
WEED has a Debt/Equity ratio of 0.64. This is a neutral value indicating WEED is somewhat dependend on debt financing.
WEED has a Debt to Equity ratio of 0.64. This is in the lower half of the industry: WEED underperforms 63.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z -12.75
ROIC/WACCN/A
WACC11.78%
WEED.CA Yearly LT Debt VS Equity VS FCFWEED.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 3.12 indicates that WEED has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.12, WEED is in the better half of the industry, outperforming 75.76% of the companies in the same industry.
WEED has a Quick Ratio of 2.10. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
WEED's Quick ratio of 2.10 is fine compared to the rest of the industry. WEED outperforms 78.79% of its industry peers.
Industry RankSector Rank
Current Ratio 3.12
Quick Ratio 2.1
WEED.CA Yearly Current Assets VS Current LiabilitesWEED.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

3

3. Growth

3.1 Past

WEED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.57%, which is quite impressive.
The Revenue has decreased by -9.49% in the past year.
Measured over the past years, WEED shows a decrease in Revenue. The Revenue has been decreasing by -7.57% on average per year.
EPS 1Y (TTM)34.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.72%
Revenue 1Y (TTM)-9.49%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-6.22%

3.2 Future

WEED is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.29% yearly.
WEED is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.64% yearly.
EPS Next Y89.5%
EPS Next 2Y38.49%
EPS Next 3Y23.41%
EPS Next 5Y15.29%
Revenue Next Year7.13%
Revenue Next 2Y6.99%
Revenue Next 3Y5.97%
Revenue Next 5Y4.64%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WEED.CA Yearly Revenue VS EstimatesWEED.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
WEED.CA Yearly EPS VS EstimatesWEED.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -20 -40 -60

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WEED. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WEED. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WEED.CA Price Earnings VS Forward Price EarningsWEED.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WEED.CA Per share dataWEED.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

WEED's earnings are expected to grow with 23.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.49%
EPS Next 3Y23.41%

0

5. Dividend

5.1 Amount

WEED does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CANOPY GROWTH CORP

TSX:WEED (7/22/2025, 7:00:00 PM)

1.69

+0.15 (+9.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-30 2025-05-30/bmo
Earnings (Next)08-08 2025-08-08/bmo
Inst Owners8.19%
Inst Owner ChangeN/A
Ins Owners0.94%
Ins Owner ChangeN/A
Market Cap357.35M
Analysts46.67
Price Target3.02 (78.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-153.89%
Min EPS beat(2)-206.63%
Max EPS beat(2)-101.15%
EPS beat(4)0
Avg EPS beat(4)-194.79%
Min EPS beat(4)-240.27%
Max EPS beat(4)-101.15%
EPS beat(8)1
Avg EPS beat(8)-180.52%
EPS beat(12)1
Avg EPS beat(12)-197.59%
EPS beat(16)4
Avg EPS beat(16)-139.13%
Revenue beat(2)2
Avg Revenue beat(2)6.85%
Min Revenue beat(2)6.06%
Max Revenue beat(2)7.65%
Revenue beat(4)2
Avg Revenue beat(4)1.32%
Min Revenue beat(4)-8.11%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)4.78%
Revenue beat(12)6
Avg Revenue beat(12)0.48%
Revenue beat(16)7
Avg Revenue beat(16)-2.12%
PT rev (1m)-16.7%
PT rev (3m)-21.49%
EPS NQ rev (1m)-25.7%
EPS NQ rev (3m)-25.7%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-9.49%
Revenue NQ rev (3m)-9.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.33
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB 1.01
EV/EBITDA N/A
EPS(TTM)-5.66
EYN/A
EPS(NY)-0.59
Fwd EYN/A
FCF(TTM)-0.84
FCFYN/A
OCF(TTM)-0.78
OCFYN/A
SpS1.27
BVpS2.3
TBVpS1.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.18%
ROE -122.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.3%
FCFM N/A
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 26.16%
Cap/Sales 4.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.12
Quick Ratio 2.1
Altman-Z -12.75
F-Score5
WACC11.78%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-42.72%
EPS Next Y89.5%
EPS Next 2Y38.49%
EPS Next 3Y23.41%
EPS Next 5Y15.29%
Revenue 1Y (TTM)-9.49%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%-6.22%
Revenue Next Year7.13%
Revenue Next 2Y6.99%
Revenue Next 3Y5.97%
Revenue Next 5Y4.64%
EBIT growth 1Y48.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.26%
EBIT Next 3Y30.78%
EBIT Next 5Y20.32%
FCF growth 1Y38.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.21%
OCF growth 3YN/A
OCF growth 5YN/A